Clinical Trial Update: Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating the use of Pentaglobin as personalized adjunct therapy after surgical source control in patients with peritonitis. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritonitis
• Sepsis
• Septic Shock

Drugs mentioned

• Pentaglobin (IgM-enriched polyclonal immunoglobulin)

Snippet

Sponsor: RWTH Aachen University | Conditions: Peritonitis, Sepsis | Phase 2 | Status: RECRUITING